Month: April 2017

Notizia

Notizia

Malaysia calls for phase 4 Dengvaxia study before considering full approval Already struggling to meet initial expectations, Sanofi...

Read More

CRISPR finds faults in previous researches

Snippets

Jason Sheltzer, a cancer biologist at Cold Spring Harbor Laboratory in New York, was on the hunt for genes involved in tumour growth. He...

Read More

Hemophilia A- Market Scenario

Articles

Hemophilia is the most common inherited bleeding disorder which leads to spontaneous bleeding as the blood does not clot properly....

Read More

The Business Cocktail

The Business Cocktail

Valeant’s asset-sale woes continue as Stada, Mundipharma lowball iNova bids Embattled Valeant has promised its investors $8 billion...

Read More

Notizia

Notizia

Biogen triumphs in latest Tecfidera patent dispute Biogen has prevailed in a patent squabble with Denmark’s Forward Pharma over multiple...

Read More

Narcolepsy: Treatment options and market outlook

Articles

Narcolepsy is characterized by symptoms such as excessive daytime sleepiness, cataplexy (sudden loss of muscle control, often triggered by...

Read More
Close